Does diabetes have a protective effect on migraine?

Epidemiology

Volumn 24, Issue 1, 2013, Pages 129-134

  Berge, Line Iden ^a,b   Riise, Trond ^a   Fasmer, Ole Bernt ^a,b   Hundal, Øivind ^b,c   Oedegaard, Ketil Joachim ^a,b   Midthjell, Kristian ^d   Lund, Anders ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c Apotekene Vest HF   (Norway)

^d NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ERGOTAMINE DERIVATIVE; INSULIN; ORAL ANTIDIABETIC AGENT; TRIPTAN DERIVATIVE;

ADULT; AGE; AGED; ARTICLE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; FEMALE; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MIGRAINE; NORWAY; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; ERGOTAMINES; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INFANT; LOGISTIC MODELS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; NORWAY; ODDS RATIO; PREVALENCE; SEX FACTORS; TRYPTAMINES; VASOCONSTRICTOR AGENTS; YOUNG ADULT;

EID: 84871804614     PISSN: 10443983     EISSN: 15315487     Source Type: Journal    
DOI: 10.1097/EDE.0b013e31827623d0     Document Type: Article

References (25)

1. International Diabetes Federation. IDF Diabetes Atlas. 5th ed. Brussels, Belgium: International Diabetes Federation; 2011.
2. Burn WK, Machin D, Waters WE. Prevalence of migraine in patients with diabetes. Br Med J (Clin Res Ed). 1984;289:1579-1580. (Pubitemid 15220622)
3. Kurth T, Gaziano JM, Cook NR, Logroscino G, Diener HC, Buring JE. Migraine and risk of cardiovascular disease in women. JAMA. 2006;296:283-291. (Pubitemid 44079312)
4. Davey G, Sedgwick P, Maier W, Visick G, Strachan DP, Anderson HR. Association between migraine and asthma: matched case-control study. Br J Gen Pract. 2002;52:723-727. (Pubitemid 36187594)
5. Split W, Szydlowska M. Headaches in non insulin-dependent diabetes mellitus. Funct Neurol. 1997;12:327-332. (Pubitemid 28156650)
6. Aamodt AH, Stovner LJ, Midthjell K, Hagen K, Zwart JA. Headache prevalence related to diabetes mellitus. The Head-HUNT study. Eur J Neurol. 2007;14:738-744. (Pubitemid 47012168)
7. Furu K. Establishment of the nation wise Norwegian Prescription Database (NorPD)-new opportunities for research in pharmacoepidemiology in Norway. Nor J Epidemiol. 2008;18:125-136.
8. Norwegian National Register of Prescriptions (NorPd). Available at: http://www.reseptregisteret.no. Accessed 15 October 2009.
9. Goadsby PJ, Sprenger T. Current practice and future directions in the prevention and acute management of migraine. Lancet Neurol. 2010;9:285-298.
10. Claudi T, Ingskog W, Cooper JG, Jenum AK, Hausken MF. [Quality of diabetes care in Norwegian general practice]. Tidsskr Nor Laegeforen. 2008;128:2570-2574.
11. Diabetesforbundet. Available at: http://www.diabetes.no/Type+2-diabetes. 9UFRnQ4P.ips. Accessed 5 April 2012.
12. Midthjell K, Krüger O, Holmen J, et al. Rapid changes in the prevalence of obesity and known diabetes in an adult Norwegian population. The Nord-Trøndelag Health Surveys: 1984-1986 and 1995-1997. Diabetes Care. 1999;22:1813-1820. (Pubitemid 29521867)
13. Holmen J, Midthjell K, Krger Ø, et al. The Nord-Trøndelag Health Study 1995-97 (HUNT 2): objectives, contents, methods and participation. Nor J Epidemiol. 2003;13:19-32.
14. Hagen K, Zwart JA, Vatten L, Stovner LJ, Bovim G. Prevalence of migraine and non-migrainous headache-head-HUNT, a large population-based study. Cephalalgia. 2000;20:900-906. (Pubitemid 32336717)
15. Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care. 1979;2:120-126. (Pubitemid 9238733)
16. Booth GL, Kapral MK, Fung K, Tu JV. Recent trends in cardiovascular complications among men and women with and without diabetes. Diabetes Care. 2006;29:32-37. (Pubitemid 44033427)
17. Schürks M, Rist PM, Shapiro RE, Kurth T. Migraine and mortality: a systematic review and meta-analysis. Cephalalgia. 2011;31:1301-1314.
18. Peterlin BL, Rosso AL, Rapoport AM, Scher AI. Obesity and migraine: the effect of age, gender and adipose tissue distribution. Headache. 2010;50:52-62.
19. Cutrer FM, Charles A. The neurogenic basis of migraine. Headache. 2008;48:1411-1414.
20. Goadsby PJ. Pathophysiology of migraine. Neurol Clin. 2009;27:335-360.
21. Káplár M, Paragh G, Erdei A, et al. Changes in cerebral blood flow detected by SPECT in type 1 and type 2 diabetic patients. J Nucl Med. 2009;50:1993-1998.
22. Ribeiro-Oliveira A Jr, Nogueira AI, Pereira RM, Boas WW, Dos Santos RA, Simões e Silva AC. The renin-angiotensin system and diabetes: an update. Vasc Health Risk Manag. 2008;4:787-803.
23. Tronvik E, Stovner LJ, Schrader H, Bovim G. Involvement of the renin-angiotensin system in migraine. J Hypertens Suppl. 2006;24:S139-S143. (Pubitemid 44336835)
24. Malik RA, Williamson S, Abbott C, et al. Effect of angiotensin- converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomised double-blind controlled trial. Lancet. 1998;352:1978-1981. (Pubitemid 29000865)
25. European Medicines Agency. Available at: http://www.ema.europa.eu/ema/ index.jsp?curl=pages/home/Home-Page.jsp&mid=. Accessed 5 August 2012.